FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213305440> ?p ?o ?g. }

• W4213305440 endingPage "100398" @default.
• W4213305440 startingPage "100398" @default.
• W4213305440 abstract "The number of randomized trials of agents targeting oncogene-addicted tumors has surged in the past 10 years. Using a meta-analysis, we explored whether improvements in objective response rate (ORR) in comparative trials using targeted agents could serve as a potential surrogate endpoint for improvements in progression-free survival (PFS) or overall survival (OS) in populations with oncogene-addicted cancer.Using commercial text mining software I2E, we searched ClinicalTrials.gov and MEDLINE databases for randomized, phase III trials based on prospectively defined criteria, including (i) use of agents targeting EGFR activating mutations, ALK rearrangements, BRAF V600E or V600K mutations, and BCR-ABL fusion protein; (ii) molecularly enriched trial population or subpopulation; (iii) control arm only randomized to chemo/cytotoxic therapy. Correlative analyses were performed using ORR, OS, and PFS data from trials that met these criteria.A total of 62 trials were identified; 15 met all of the prespecified criteria. The ORR effect size (both the difference in ORR between arms and the log odds ratio) and log PFS hazard ratio were strongly correlated: -0.78 (P = 0.0007) for the ORR difference model; -0.74 (P = 0.0017) for the log odds ratio model. ORR effect size was positively correlated with the log OS hazard ratio, but more weakly: -0.67 (P = 0.013) for the ORR difference model and -0.58 (P = 0.036) for the log odds ratio model. Analysis of the treatment effects between OS and PFS found no correlation.These analyses identified a strong correlation between treatment effects on ORR and PFS in randomized clinical trials investigating agents targeting oncogene-driven cancers. A weaker correlation was observed between ORR and OS. These meta-analysis results support the use of a high ORR forming the basis of an initial regulatory approval in biomarker-driven studies." @default.
• W4213305440 created "2022-02-24" @default.
• W4213305440 creator A5023811099 @default.
• W4213305440 creator A5033539889 @default.
• W4213305440 creator A5045959942 @default.
• W4213305440 creator A5049418949 @default.
• W4213305440 creator A5063199354 @default.
• W4213305440 creator A5065082643 @default.
• W4213305440 creator A5068475432 @default.
• W4213305440 creator A5073391094 @default.
• W4213305440 creator A5087050668 @default.
• W4213305440 creator A5088319794 @default.
• W4213305440 date "2022-04-01" @default.
• W4213305440 modified "2023-10-17" @default.
• W4213305440 title "Correlation between treatment effects on response rate and progression-free survival and overall survival in trials of targeted therapies in molecularly enriched populations" @default.
• W4213305440 cites W1985046983 @default.
• W4213305440 cites W2028959752 @default.
• W4213305440 cites W2030411079 @default.
• W4213305440 cites W2050249255 @default.
• W4213305440 cites W2096198395 @default.
• W4213305440 cites W2099530756 @default.
• W4213305440 cites W2111662961 @default.
• W4213305440 cites W2122553809 @default.
• W4213305440 cites W2124967121 @default.
• W4213305440 cites W2133149289 @default.
• W4213305440 cites W2149654081 @default.
• W4213305440 cites W2151337547 @default.
• W4213305440 cites W2152481222 @default.
• W4213305440 cites W2166084034 @default.
• W4213305440 cites W2171139285 @default.
• W4213305440 cites W2336162936 @default.
• W4213305440 cites W2784538417 @default.
• W4213305440 cites W2796631032 @default.
• W4213305440 cites W2801531086 @default.
• W4213305440 cites W2887380463 @default.
• W4213305440 cites W3007953816 @default.
• W4213305440 cites W3081278682 @default.
• W4213305440 cites W3082062836 @default.
• W4213305440 doi "https://doi.org/10.1016/j.esmoop.2022.100398" @default.
• W4213305440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35183043" @default.
• W4213305440 hasPublicationYear "2022" @default.
• W4213305440 type Work @default.
• W4213305440 citedByCount "4" @default.
• W4213305440 countsByYear W42133054402022 @default.
• W4213305440 countsByYear W42133054402023 @default.
• W4213305440 crossrefType "journal-article" @default.
• W4213305440 hasAuthorship W4213305440A5023811099 @default.
• W4213305440 hasAuthorship W4213305440A5033539889 @default.
• W4213305440 hasAuthorship W4213305440A5045959942 @default.
• W4213305440 hasAuthorship W4213305440A5049418949 @default.
• W4213305440 hasAuthorship W4213305440A5063199354 @default.
• W4213305440 hasAuthorship W4213305440A5065082643 @default.
• W4213305440 hasAuthorship W4213305440A5068475432 @default.
• W4213305440 hasAuthorship W4213305440A5073391094 @default.
• W4213305440 hasAuthorship W4213305440A5087050668 @default.
• W4213305440 hasAuthorship W4213305440A5088319794 @default.
• W4213305440 hasBestOaLocation W42133054401 @default.
• W4213305440 hasConcept C126322002 @default.
• W4213305440 hasConcept C143998085 @default.
• W4213305440 hasConcept C156957248 @default.
• W4213305440 hasConcept C168563851 @default.
• W4213305440 hasConcept C203092338 @default.
• W4213305440 hasConcept C207103383 @default.
• W4213305440 hasConcept C2780739268 @default.
• W4213305440 hasConcept C2908647359 @default.
• W4213305440 hasConcept C3019894029 @default.
• W4213305440 hasConcept C44249647 @default.
• W4213305440 hasConcept C71924100 @default.
• W4213305440 hasConcept C95190672 @default.
• W4213305440 hasConcept C99454951 @default.
• W4213305440 hasConceptScore W4213305440C126322002 @default.
• W4213305440 hasConceptScore W4213305440C143998085 @default.
• W4213305440 hasConceptScore W4213305440C156957248 @default.
• W4213305440 hasConceptScore W4213305440C168563851 @default.
• W4213305440 hasConceptScore W4213305440C203092338 @default.
• W4213305440 hasConceptScore W4213305440C207103383 @default.
• W4213305440 hasConceptScore W4213305440C2780739268 @default.
• W4213305440 hasConceptScore W4213305440C2908647359 @default.
• W4213305440 hasConceptScore W4213305440C3019894029 @default.
• W4213305440 hasConceptScore W4213305440C44249647 @default.
• W4213305440 hasConceptScore W4213305440C71924100 @default.
• W4213305440 hasConceptScore W4213305440C95190672 @default.
• W4213305440 hasConceptScore W4213305440C99454951 @default.
• W4213305440 hasIssue "2" @default.
• W4213305440 hasLocation W42133054401 @default.
• W4213305440 hasLocation W42133054402 @default.
• W4213305440 hasLocation W42133054403 @default.
• W4213305440 hasOpenAccess W4213305440 @default.
• W4213305440 hasPrimaryLocation W42133054401 @default.
• W4213305440 hasRelatedWork W1900595920 @default.
• W4213305440 hasRelatedWork W2047252483 @default.
• W4213305440 hasRelatedWork W2286371484 @default.
• W4213305440 hasRelatedWork W2318119155 @default.
• W4213305440 hasRelatedWork W2889691785 @default.
• W4213305440 hasRelatedWork W2976179431 @default.
• W4213305440 hasRelatedWork W3004966710 @default.
• W4213305440 hasRelatedWork W3017329712 @default.
• W4213305440 hasRelatedWork W3038392370 @default.

• next